awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q52603250-E98FE204-377B-433F-A763-8C46F4B74354
Q52603250-E98FE204-377B-433F-A763-8C46F4B74354
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52603250-E98FE204-377B-433F-A763-8C46F4B74354
Applying a Multicriteria Decision Analysis (MCDA) Approach to Elicit Stakeholders' Preferences in Italy: The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma (iNHL).
P2860
Q52603250-E98FE204-377B-433F-A763-8C46F4B74354
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52603250-E98FE204-377B-433F-A763-8C46F4B74354
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
294f8c67aadae7168f067e1f05aa859af3e7b16b
P2860
Identification of potential surrogate end points in randomized clinical trials of aggressive and indolent non-Hodgkin's lymphoma: correlation of complete response, time-to-event and overall survival end points